Admission Viscoelastic Hemostatic Assay Parameters Predict Poor Long-Term Intracerebral Hemorrhage Outcomes.
Laura SiehEmma PeasleyEric MaoAmanda MitchellGregory HeinonenShivani GhoshalSachin AgarwalSoojin ParkE Sander ConnollyJan ClaassenErnest E MooreKirk HansenEldad A HodRichard O FrancisDavid J RohPublished in: Neurocritical care (2024)
Slower, prolonged coagulation kinetics and weaker clot strength on admission VHA ROTEM testing, not attributable to anticoagulant use, were associated with poor long-term outcomes after ICH. Further work is needed to clarify the generalizability and the underlying mechanisms of these VHA findings to assess whether VHA-guided treatments should be incorporated into ICH care.